Results 181 to 190 of about 259,590 (298)

Antiretroviral therapy [PDF]

, 2011
openaire   +1 more source

2025 Consensus Clinical Management Guidelines for Niemann‐Pick Disease Type C

Journal of Inherited Metabolic Disease, Volume 49, Issue 3, May 2026.
ABSTRACT In 2018, the International Niemann‐Pick Disease Alliance (INPDA) and the International Niemann‐Pick Disease Registry (INPDR) developed and published comprehensive clinical management guidelines to support inclusive and standardized care pathways in Niemann‐Pick disease type C (NPC)—an ultra‐rare, autosomal recessive, neurovisceral lysosomal ...
Tarekegn Hiwot, Forbes D. Porter, Tatiana Bremova‐Ertl, Uma Ramaswami, Caroline Hastings, Bénédicte Héron, Justin Hopkin, Joella Melville, Hernan Amartino, Mireia del Toro, Federica Deodato, Fatih Ezgü, Paul Gissen, James B. Gibson, Can Ficicioglu, Roberto Giugliani, Orna Staretz‐Chacham, Frances Platt, Nathalie Guffon, Kristina Julich, Nikola Kresojević, Anna Lehman, Yann Nadjar, Susanne A. Schneider, Simon Jones, Eugen Mengel, Michel Tchan, Mark Walterfang, Ozlem Goker‐Alpan, Charlotte Dawson, Sandra Cowie, Toni Mathieson, Elizabeth Berry‐Kravis, Marc C. Patterson   +33 more
wiley   +1 more source

Perceptions of adolescents and young adults failing antiretroviral therapy on adherence in Gauteng, South Africa. [PDF]

South Afr J HIV Med
Molete RM, Makua MG, Ndlazi BE.
europepmc   +1 more source

Comparative Evaluation of the New HIV VIDAS® DUO AG/AB Assay With DUO Ultra on Well Characterized Participants From the HIV‐1 Acute Infection French ANRS PRIMO Cohort

Journal of Medical Virology, Volume 98, Issue 5, May 2026.
ABSTRACT Diagnosing HIV‐1 infection as early as the primary infection is crucial. In this context, we performed a comparative evaluation and agreement analysis of the newly proposed serological assay for the combined detection of total antibodies against HIV and P24 antigen (HIV VIDAS® DUO AG/AB, bioMérieux®), with the previously available HIV VIDAS ...
Gilbert Mchantaf, Xavier Maia, Valérie Andriantsoanirina, Océane Dehan, Karl Stefic, Laurent Hocqueloux, Olivier Robineau, Alain Makinson, Cécile Goujard, Laurence Meyer, Véronique Avettand‐Fenoel, ANRS PRIMO cohort   +11 more
wiley   +1 more source

Factors Associated With Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda. [PDF]

J Acquir Immune Defic Syndr
Nutt CT, Muyindike WR, Nanfuka V, Komukama N, Barigye IT, Kansiime L, Tumusiime J, Omoding D, Aung TN, Stuckwisch A, Hedt-Gauthier B, Hoeppner SS, Marconi VC, Moosa MS, Gupta RK, Siedner MJ, McCluskey SM.   +16 more
europepmc   +1 more source

Discovery of 4‐Quinazolinone‐Containing Phenylalanine Derivatives as Potent, Resistant‐Tolerant HIV Capsid Inhibitors

MedComm, Volume 7, Issue 5, May 2026.
Novel phenylalanine derivatives were identified as HIV‐1 capsid inhibitors. IC‐2i showed significant anti‐HIV‐1 activity at picomolar concentrations. ABSTRACT The HIV‐1 capsid (CA) is a validated antiviral target that plays critical roles in both the early and late stages of the viral life cycle.
Xujie Zhang, Lin Sun, Laura Walsham, Yuexi Ma, Dang Ding, Mei Wang, Fabao Zhao, Jian Zhang, Zhao Wang, Shujing Xu, Xiangyi Jiang, Yang Zhou, Erik De Clercq, Christophe Pannecouque, Chin‐Ho Chen, David C. Goldstone, Xinyong Liu, Alexej Dick, Peng Zhan   +18 more
wiley   +1 more source

Timing of maternal antiretroviral therapy initiation and HIV status of children at 18 months in Ibadan, Nigeria. [PDF]

BMC Infect Dis
Olowolafe TA, Adetoro OJ, Salawu MM, Adeoye IA.   +3 more
europepmc   +1 more source

Determinants of Cardiovascular Disease Risk Among LGBTQ+ Populations: A Systematic Review of Empirical Evidence

Nursing Open, Volume 13, Issue 5, May 2026.
ABSTRACT Background Understanding the multifactorial drivers of cardiovascular disease (CVD) risk in LGBTQ+ populations is critical to advancing equitable cardiovascular care. Objective To evaluate and synthesize empirical evidence on factors influencing CVD risk among sexual minority populations.
Sarinrut Sriprasong, Kritsadakorn Sukumanukoon, Naruewat Chantab, Nanthiya Chaosangkate, Suebsarn Ruksakulpiwat   +4 more
wiley   +1 more source

Interplay Between Oral Microbiota and Mouth Health in People Living With HIV Under Antiretroviral Therapy With or Without Periodontitis. [PDF]

Int J Dent
Ramos Peña DE, Boussetta-Charfi O, Antezack A, Amroune N, Colson P, Monnet-Corti V, Saia RS, Guillemot J, Pozzetto B, Pillet S, La Scola B, Bourlet T, Fragoso Motta AC.   +12 more
europepmc   +1 more source

Pharmacokinetics, Pharmacodynamics, Efficacy and Drug Resistance Selection of Injectable Long‐Acting Lenacapavir Pre‐Exposure Prophylaxis (PrEP) Against HIV

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 5, May 2026.
ABSTRACT Oral pre‐exposure prophylaxis (PrEP) can substantially reduce HIV infection risk when taken as prescribed. However, many individuals struggle adhering to the daily regimen. Twice‐yearly injections of the novel HIV capsid inhibitor lenacapavir (LEN) demonstrated potential in recent PrEP trials.
Hee‐yeong Kim, Antonia Liebenberg, Lanxin Zhang, Max von Kleist   +3 more
wiley   +1 more source